Latest 10-K annual reports

Opus Genetics, a clinical-stage biopharmaceutical company, reported positive clinical trial results for its lead gene therapies, OPGx-LCA5 and OPGx-BEST1, alongside reduced net losses and increased cash reserves for fiscal year 2025.

Stereotaxis, Inc. reported a 20% revenue increase in 2025, driven by system sales and disposable devices, alongside key regulatory approvals for new robotic navigation products, despite continued net losses.

ON24, Inc. reported a 6% decrease in total revenue for 2025, alongside a reduced net loss, as it navigates a proposed merger with Cvent Atlanta, LLC.

Acacia Research Corporation reported a significant increase in total revenues for the fiscal year ended December 31, 2025, driven by growth in its Intellectual Property, Energy, and Manufacturing Operations, alongside strategic acquisitions.

Omega Flex, a leading flexible metal hose manufacturer, reported a 3.3% decrease in net sales and a 21.5% drop in operating profit for 2025, primarily due to a suppressed housing market.

GRAIL reports increased Galleri sales and reduced net losses in 2025, but faces challenges with a missed primary endpoint in the NHS-Galleri Trial and ongoing regulatory hurdles for broad reimbursement.

GoPro, Inc. reported a net loss of $93.5 million for fiscal year 2025 on declining revenue, driven by macroeconomic headwinds and increased competition, while outlining strategic shifts towards new product innovation and cost management.

Inflection Point Acquisition Corp. IV's shareholders approved its business combination with Merlin Labs, Inc., an AI-driven aerospace company, with closing expected by March 16, 2026.

WM Technology, Inc. reported a 5% decrease in revenues to $174.7 million for fiscal year 2025, alongside a significant drop in net income and ongoing material weaknesses in internal controls.

Funko reported a 13.5% revenue decline and a wider net loss for 2025, amended its credit facility to extend maturities and loosen covenants, and increased shares under its inducement plan.

Pioneer Bancorp, Inc. reported a 32.9% increase in net income to $20.3 million for the year ended December 31, 2025, driven by loan growth and strategic diversification into wealth management and municipal bond trading.

Weis Markets, Inc. has restated past financial statements due to inventory overstatement caused by employee misconduct, revealing material weaknesses in internal controls.

CareCloud, Inc. announced a 9% revenue increase and a 37.5% rise in GAAP net income for 2025, driven by strategic acquisitions and significant investment in AI technology, while also addressing preferred stock dividend arrears.

Addus HomeCare Corporation filed an amendment to its 2025 annual report to include previously omitted insider trading and compensation recoupment policies.

TransAct Technologies Inc. reported a net loss of $1.2 million for 2025, a significant improvement from the prior year, alongside a strategic acquisition of the BOHA! software source code.

American Public Education, Inc. reports its 2025 annual results, highlighting strategic shifts and financial objectives.

Synlogic, a biopharmaceutical company, has discontinued its lead clinical program and delisted from Nasdaq, now focusing on strategic alternatives as a public shell company.

Plus Therapeutics reports significant net losses and going concern doubts for fiscal year 2025, while advancing its CNS cancer radiopharmaceutical and diagnostic pipeline with key clinical milestones and commercial agreements.

Grayscale Zcash Trust (ZEC) saw its net assets surge by 809% in 2025, driven by significant Zcash price appreciation, despite continued trading at a discount to NAV.

Sonida Senior Living completed a major acquisition of CNL Healthcare Properties, significantly expanding its portfolio while reporting a substantial net loss for 2025 amidst rising operating expenses and debt.

Orrstown Financial Services, Inc. reported a significant increase in net income and total assets for 2025, driven by the successful integration of the Codorus Valley Merger and strategic loan growth.

Grayscale XRP Trust ETF reports a net decrease in assets from operations for 2025, despite its recent NYSE Arca listing and a significant fee reduction.

Adicet Bio reports positive preliminary Phase 1 results for prula-cel in autoimmune diseases, plans pivotal trials, and secures financing while facing substantial losses.

Grayscale Stellar Lumens Trust (XLM) filed its transition report, detailing a fiscal year-end change and reporting a significant net asset decrease for the three months ended December 31, 2025, driven by XLM price depreciation.

Team Inc. reported a 5.2% revenue increase to $896.5 million in 2025, alongside a higher net loss of $49.2 million, while successfully executing significant debt and equity refinancing transactions.

Grayscale Solana Staking ETF's 2025 annual report reveals a net decrease in assets from operations due to SOL price depreciation, despite successful NYSE Arca uplisting and staking initiation.

Grayscale Horizen Trust (ZEN) announces a change in its fiscal year-end to December 31, effective January 1, 2025, and reports a net increase in net assets from operations of $1,192 thousand for the three months ended December 31, 2025.

Grayscale Ethereum Classic Trust (ETC) reported a significant 55% decrease in net assets for the year ended December 31, 2025, primarily due to ETC price depreciation.

Grayscale Dogecoin Trust ETF's 2025 annual report reveals a significant net loss and DOGE price depreciation, despite its uplisting to NYSE Arca and a reduced sponsor fee.

Bitwise Ethereum ETF experienced a net decrease in assets and an 11.19% decline in NAV per share in 2025, driven by a drop in ether prices and significant redemptions.